GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 54 filers reported holding GENERATION BIO CO in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,405,567 | -31.7% | 370,862 | -0.9% | 0.00% | – |
| Q2 2023 | $2,058,574 | +24.3% | 374,286 | -2.8% | 0.00% | – |
| Q1 2023 | $1,655,891 | -0.9% | 385,091 | -9.4% | 0.00% | – |
| Q4 2022 | $1,670,823 | -24.0% | 425,146 | +2.8% | 0.00% | -100.0% |
| Q3 2022 | $2,198,000 | -18.8% | 413,698 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $2,707,000 | -8.8% | 412,585 | +2.1% | 0.00% | 0.0% |
| Q1 2022 | $2,967,000 | -0.3% | 404,176 | -3.8% | 0.00% | – |
| Q4 2021 | $2,975,000 | -72.7% | 420,184 | -3.5% | 0.00% | -100.0% |
| Q3 2021 | $10,917,000 | +0.1% | 435,516 | +7.4% | 0.00% | 0.0% |
| Q2 2021 | $10,906,000 | -1.1% | 405,430 | +4.6% | 0.00% | 0.0% |
| Q1 2021 | $11,027,000 | +160.1% | 387,472 | +159.2% | 0.00% | +100.0% |
| Q4 2020 | $4,239,000 | -8.4% | 149,495 | -0.1% | 0.00% | 0.0% |
| Q3 2020 | $4,626,000 | – | 149,679 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |